Dylan Beynon is the founder and CEO of Mindbloom. Minbloom's mission is to transform lives today, to transform the world tomorrow through psychedelic medicine. It's starting with Ketamine therapy serving patients with depression and anxiety. 89% of Mindbloom clients report improvements in anxiety and depression symptoms. Beyond Ketamine therapy, Mindbloom is riding a wave of new research and regulation that's mainstreaming psychedelics for clinical use and shaping how approach physical, emotional, and mental wellbeing. --- Send in a voice message: https://podcasters.spotify.com/pod/show/notboring/message